NanoVation Therapeutics
NanoVation Therapeutics develops innovative lipid nanoparticle (LNP) technologies for nucleic acid delivery, overcoming limitations of existing approaches, particularly in targeting tissues outside the liver. Their lead technology, lcLNP™, enables functional nucleic acid delivery to extrahepatic cell types and shows improved therapeutic index in preclinical studies. The company partners with pharmaceutical and biotech firms to develop genetic medicines.
Funding Round:
Funding Amount:
Date: 19-Nov-2024
Investors: Convergent Ventures
Markets: Biotechnology, Pharmaceuticals, Genetic Medicines, Lipid Nanoparticle Technology, Nanotechnology, Therapeutics
HQ: Vancouver, British Columbia, Canada
Founded: 2020
Website: https://www.nanovationtx.com/
LinkedIn: https://www.linkedin.com/company/nanovationtx/
Crunchbase: https://www.crunchbase.com/organization/nanovation-therapeutics
Leave a Comment
Comments
No comments yet.